BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 25523477)

  • 1. Changes in urinary angiotensinogen posttreatment in pediatric IgA nephropathy patients.
    Urushihara M; Nagai T; Kinoshita Y; Nishiyama S; Suga K; Ozaki N; Jamba A; Kondo S; Kobori H; Kagami S
    Pediatr Nephrol; 2015 Jun; 30(6):975-82. PubMed ID: 25523477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrarenal renin-angiotensin system activation and macrophage infiltrations in pediatric chronic glomerulonephritis.
    Hattori T; Fujioka K; Nagai T; Kondo S; Kagami S; Hirayama M; Urushihara M
    Pediatr Nephrol; 2023 Nov; 38(11):3711-3719. PubMed ID: 37231123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary angiotensinogen as a novel biomarker of the intrarenal renin-angiotensin system status in hypertensive patients.
    Kobori H; Alper AB; Shenava R; Katsurada A; Saito T; Ohashi N; Urushihara M; Miyata K; Satou R; Hamm LL; Navar LG
    Hypertension; 2009 Feb; 53(2):344-50. PubMed ID: 19075095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary angiotensinogen accurately reflects intrarenal Renin-Angiotensin system activity.
    Urushihara M; Kondo S; Kagami S; Kobori H
    Am J Nephrol; 2010; 31(4):318-25. PubMed ID: 20160435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glomerular angiotensinogen protein is enhanced in pediatric IgA nephropathy.
    Takamatsu M; Urushihara M; Kondo S; Shimizu M; Morioka T; Oite T; Kobori H; Kagami S
    Pediatr Nephrol; 2008 Aug; 23(8):1257-67. PubMed ID: 18421480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of dual blockade of the renin-angiotensin system on urinary protein and transforming growth factor-beta excretion in 2 groups of patients with IgA and diabetic nephropathy.
    Song JH; Lee SW; Suh JH; Kim ES; Hong SB; Kim KA; Kim MJ
    Clin Nephrol; 2003 Nov; 60(5):318-26. PubMed ID: 14640237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary angiotensinogen reflects the activity of intrarenal renin-angiotensin system in patients with IgA nephropathy.
    Nishiyama A; Konishi Y; Ohashi N; Morikawa T; Urushihara M; Maeda I; Hamada M; Kishida M; Hitomi H; Shirahashi N; Kobori H; Imanishi M
    Nephrol Dial Transplant; 2011 Jan; 26(1):170-7. PubMed ID: 20615910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ELISA examining urinary angiotensinogen as a potential indicator of intrarenal renin-angiotensin system (RAS) activity: a clinical study of 128 chronic kidney disease patients.
    Zhang XY; Ding XQ; Lv WL; Teng J; Zhong YH
    Mol Biol Rep; 2013 Oct; 40(10):5817-24. PubMed ID: 24065527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrarenal RAS activity and urinary angiotensinogen excretion in anti-thymocyte serum nephritis rats.
    Ohashi N; Yamamoto T; Huang Y; Misaki T; Fukasawa H; Suzuki H; Togawa A; Suzuki S; Fujigaki Y; Nakagawa T; Nakamura Y; Suzuki F; Kitagawa M; Hishida A
    Am J Physiol Renal Physiol; 2008 Nov; 295(5):F1512-8. PubMed ID: 18784264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary angiotensinogen as a predictive marker in patients with immunoglobulin A nephropathy.
    Kim YG; Song SB; Lee SH; Moon JY; Jeong KH; Lee TW; Ihm CG
    Clin Exp Nephrol; 2011 Oct; 15(5):720-726. PubMed ID: 21695414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precocious activation of genes of the renin-angiotensin system and the fibrogenic cascade in IgA glomerulonephritis.
    Del Prete D; Gambaro G; Lupo A; Anglani F; Brezzi B; Magistroni R; Graziotto R; Furci L; Modena F; Bernich P; Albertazzi A; D'Angelo A; Maschio G
    Kidney Int; 2003 Jul; 64(1):149-59. PubMed ID: 12787405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction in urinary angiotensinogen levels and improvement of proteinuria by renin-angiotensin system blockade in pediatric chronic kidney disease patients with very low birth weight.
    Yamamura-Miyazaki N; Michigami T; Satomura K; Urushihara M; Kagami S; Yamamoto K
    Pediatr Nephrol; 2020 Jul; 35(7):1307-1314. PubMed ID: 32162100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensinogen gene variation and renoprotective efficacy of renin-angiotensin system blockade in IgA nephropathy.
    Narita I; Goto S; Saito N; Song J; Omori K; Kondo D; Sakatsume M; Gejyo F
    Kidney Int; 2003 Sep; 64(3):1050-8. PubMed ID: 12911556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered urinary excretion of aquaporin 2 in IgA nephropathy.
    Rocchetti MT; Tamma G; Lasorsa D; Suriano IV; D'Apollo A; Papale M; Mastrofrancesco L; Grandaliano G; Svelto M; Valenti G; Gesualdo L; Di Paolo S
    Eur J Endocrinol; 2011 Oct; 165(4):657-64. PubMed ID: 21824900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary angiotensinogen as a potential biomarker of intrarenal renin-angiotensin system activity in Chinese chronic kidney disease patients.
    Xu Z; Xu B; Xu C
    Ir J Med Sci; 2015 Jun; 184(2):297-304. PubMed ID: 24664631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the intrarenal renin-angiotensin system in the progression of renal disease.
    Urushihara M; Kagami S
    Pediatr Nephrol; 2017 Sep; 32(9):1471-1479. PubMed ID: 27380400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Urinary Angiotensinogen to Urinary Albumin Ratio Reflects Whether the Renin-angiotensin System in the Kidney Is Activated due to Filtration of Plasma Angiotensinogen through the Damaged Glomeruli or the Production of Angiotensinogen in the Proximal Tubules.
    Ohashi N; Aoki T; Matsuyama T; Ishigaki S; Isobe S; Katahashi N; Sato T; Fujikura T; Kato A; Yasuda H
    Intern Med; 2020 Feb; 59(3):357-364. PubMed ID: 31534091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of intrarenal renin-agiotensin system contributes to renal damage in high-salt induced hypertension rats.
    Wu H; Liang Y; Zheng Y; Bai Q; Zhuang Z; A L; Zheng D; Wang Y
    Kidney Blood Press Res; 2014; 39(6):526-35. PubMed ID: 25531334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of losartan on proteinuria and urinary angiotensinogen excretion in non-diabetic patients with chronic kidney disease.
    Lee YJ; Cho S; Kim SR; Jang HR; Lee JE; Huh W; Kim DJ; Oh HY; Kim YG
    Postgrad Med J; 2011 Oct; 87(1032):664-9. PubMed ID: 21715572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in Urinary Angiotensinogen Associated with Deterioration of Kidney Function in Patients with Type 2 Diabetes Mellitus.
    Lee MJ; Kim SS; Kim IJ; Song SH; Kim EH; Seo JY; Kim JH; Kim S; Jeon YK; Kim BH; Kim YK
    J Korean Med Sci; 2017 May; 32(5):782-788. PubMed ID: 28378551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.